A phase 3 clinical trial of duloxetine in children and adolescents with depressive disorder
Phase of Trial: Phase III
Latest Information Update: 26 Jan 2019
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Eli Lilly; Shionogi
- 26 Jan 2019 Last checked against ClinicalTrials.gov record.
- 30 Nov 2017 Status changed from not yet recruiting to recruiting.
- 21 Oct 2017 New trial record